Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010 | Zendy

Emmaculate Lebo | Zendy; Deanna KruszonMoran | Zendy; Mona Marin | Zendy; William J. Bellini | Zendy; Scott Schmid | Zendy; Stephanie R. Bialek | Zendy; Gregory S. Wallace | Zendy; Huong Q. McLean | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010

Author(s) -

Emmaculate Lebo,

Deanna KruszonMoran,

Mona Marin,

William J. Bellini,

Scott Schmid,

Stephanie R. Bialek,

Gregory S. Wallace,

Huong Q. McLean

Publication year - 2015

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofv006

Subject(s) - seroprevalence , medicine , rubella , measles , population , pediatrics , vaccination , herd immunity , virology , immunology , serology , antibody , environmental health

Background. In the United States, measles, mumps, rubella, and varicella immunity is now primarily achieved through vaccination. Monitoring population immunity is necessary. Methods. We evaluated seroprevalence of antibodies to measles, mumps, rubella, and varicella using the National Health and Nutrition Examination Survey during 2009-2010. Results. Measles, mumps, rubella, and varicella seroprevalence was 92.0% (95% confidence interval [CI], 90.9%-93.0%), 87.6% (CI, 85.8%-89.2%), 95.3% (CI, 94.3%-96.2%), and 97.8% (CI, 97.1%-98.3%), respectively. United States (US)-born persons had lower mumps seroprevalence and higher varicella seroprevalence than non-US born persons. Conclusions. Seroprevalence was high (88%-98%) for all 4 viruses in the US population during 2009-2010.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research